Latest Oncologists Stories
ORLANDO, Fla., May 18, 2014 /PRNewswire-USNewswire/ -- With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate
Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S.
‘Op-Ed on Cancer’ challenges traditional approach to cancer treatment, offers author’s 35-year experience as proof. Douglaston, N.Y.
Kia Michel, MD, of Comprehensive Urology in Los Angeles comments on the importance of seeking testicular cancer treatment after a 21-year-old’s life is saved thanks to social media platform
CAMBRIDGE, Mass., April 30, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company
NEW YORK, April 28, 2014 /PRNewswire/ -- Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical and medical information products and services,
BOTHELL, Wash. and VANCOUVER, British Columbia, April 28, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced results from the Phase 3 SYNERGY trial.
Will oversee Virginia G.
Fort Lauderdale-based event to provide stomach cancer patients and their families unparalleled access to hear from eight world-renowned experts in the field of stomach cancer FT.
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
- A political dynamiter.